Experienced in B-Cell Lymphoma

Dr. Omar A. Alkharabsheh

Hematology Oncology | Hematology | Oncology
Usa Health - Mci Business Services LLC
1660 Spring Hill Ave, 
Mobile, AL 
Accepting New Patients
Experienced in B-Cell Lymphoma
Usa Health - Mci Business Services LLC
1660 Spring Hill Ave, 
Mobile, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Omar Alkharabsheh is a Hematologist Oncology specialist and a Hematologist in Mobile, Alabama. Dr. Alkharabsheh is rated as an Experienced provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Thrombocytopenia, and Anemia. Dr. Alkharabsheh is currently accepting new patients.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of B-Cell Lymphoma.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MN
Hospital Affiliations
Usa Health University Hospital
Mobile Infirmary Medical Center
Usa Health Children's & Women's Hospital
Thomas Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

USA HEALTH - MCI BUSINESS SERVICES LLC
1660 Spring Hill Ave, Mobile, AL 36604

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
View 2 Less Clinical Trials

26 Total Publications

Urinary Stricture due to Localized Urethral AL Amyloidosis: A Case Report and Literature Review.
Urinary Stricture due to Localized Urethral AL Amyloidosis: A Case Report and Literature Review.
Journal: Case reports in oncology
Published: May 29, 2025
Similar Doctors
Distinguished in B-Cell Lymphoma
Dr. Jeffrey R. George
Hematology Oncology | Hematology | Oncology
Distinguished in B-Cell Lymphoma
Dr. Jeffrey R. George
Hematology Oncology | Hematology | Oncology

Southern Cancer Center PC

6701 Airport Blvd, 
Mobile, AL 
 (7.2 miles away)
251-625-6896
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey George is a Hematologist Oncology specialist and a Hematologist in Mobile, Alabama. Dr. George is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, B-Cell Lymphoma, and Bone Marrow Aspiration. Dr. George is currently accepting new patients.

Distinguished in B-Cell Lymphoma
Dr. David E. Mann
Hematology Oncology | Hematology | Oncology
Distinguished in B-Cell Lymphoma
Dr. David E. Mann
Hematology Oncology | Hematology | Oncology

Sacred Heart Health System Inc

1545 Airport Blvd, 
Pensacola, FL 
 (53.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Mann is a Hematologist Oncology specialist and a Hematologist in Pensacola, Florida. Dr. Mann is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Mann is currently accepting new patients.

Advanced in B-Cell Lymphoma
Dr. Thomas Johnson
Oncology | Hematology
Advanced in B-Cell Lymphoma
Dr. Thomas Johnson
Oncology | Hematology

Sacred Heart Health System Inc

1545 Airport Blvd, 
Pensacola, FL 
 (53.5 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Johnson is an Oncologist and a Hematologist in Pensacola, Florida. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alkharabsheh's expertise for a condition
ConditionClose
    View All 43 Advanced Conditions
    View All 172 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile